search
Documents
Optimized HPLC Method for Assay and Impurities/Related Substances of Semaglutide and Cagrilintide Combination using Aeris Peptide XB-C18 (TN-1400)
This technical application note details the development of precise, high-performance liquid chromatography (HPLC) methodologies for the quantitative assessment of Cagrilintide, its unidentified impurities, as well as Semaglutide and its eight related substances, utilizing the Aeris Peptide XB-C18 HPLC column.
Optimized HPLC Method for Assay and Impurities/Related Substances of Semaglutide and Cagrilintide Combination using Aeris Peptide XB-C18 (TN-1400)
This technical application note details the development of precise, high-performance liquid chromatography (HPLC) methodologies for the quantitative assessment of Cagrilintide, its unidentified impurities, as well as Semaglutide and its eight related substances, utilizing the Aeris Peptide XB-C18 HPLC column.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Reversed Phase
Phases:
Optimized HPLC Method for Assay and Impurities/Related Substances of Semaglutide and Cagrilintide Combination using Aeris Peptide XB-C18 (TN-1400)
This technical application note details the development of precise, high-performance liquid chromatography (HPLC) methodologies for the quantitative assessment of Cagrilintide, its unidentified impurities, as well as Semaglutide and its eight related substances, utilizing the Aeris Peptide XB-C18 HPLC column.
| Target Industries: | Pharmaceutical |
| Techniques: | HPLC, HPLC Reversed Phase |
| Brands: | Aeris HPLC Column |
| Separation Modes: | Reversed Phase |
| Phases: | Aeris Peptide XB-C18 |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.